Skip to main content
Rong He, MD, Pathology, Rochester, MN, Mayo Clinic Hospital - Rochester

RongHeMD

Pathology • Rochester, MN

Hematopathology, Molecular Genetics, Anatomic Pathology, Clinical Pathology

Professor, Laboratory Medicine & Pathology, Mayo Medical School

Join to view full profile

Dr. He is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. He's full profile

Already have an account?

Summary

  • Dr. Rong He is a pathologist in Rochester, MN and is affiliated with Mayo Clinic Hospital - Rochester. She received her medical degree from Hunan Medical University and has been in practice 17 years. She specializes in hematopathology, molecular genetics, anatomic pathology, and clinical pathology and is experienced in myelodysplasia, leukemia, and bleeding and thrombotic disorders. She is the co-director of the Molecular Hematopathology Lab and has more than 100 publications and over 500 citings.

Education & Training

  • Mayo Clinic College of Medicine and Science (Rochester)
    Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Hematopathology, 2010 - 2011
  • University of Wisconsin Hospitals and Clinics
    University of Wisconsin Hospitals and ClinicsResidency, Pathology-Anatomic and Clinical, 2006 - 2010
  • Hunan Medical University
    Hunan Medical UniversityClass of 1994

Certifications & Licensure

  • WI State Medical License
    WI State Medical License 2008 - 2025
  • MN State Medical License
    MN State Medical License 2010 - 2024
  • American Board of Pathology Pathology - Anatomic/Pathology - Clinical
  • American Board of Pathology Hematopathology

Publications & Presentations

PubMed

Journal Articles

  • Hybridization capture-based next generation sequencing reliably detects FLT3 mutations and classifies FLT3-internal tandem duplication allelic ratio in acute myeloid l...  
    Rong He, Daniel J. Devin1, Zheng Jin Tu, Ming Mai, Dong Chen, Phuong L. Nguyen, Jennifer L. Oliveira, James D. Hoyer, Kaaren K. Reichard, Paul L. Ollila, Aref Al-Kali,..., Modern Pathology, 8/30/2019
  • Genetic Subtyping of Breast Implant-Associated Anaplastic Large Cell Lymphoma  
    Andrew L Feldman, Garry S Brody, Rhett P Ketterling, N Nora Bennani, Mark W Clemens, Ellen D McPhail, Christin A Harless, David S Viswanatha, Rong He, Blood

Abstracts/Posters

  • Comparison of _LEPRA and _LELY Co-Inheritance with a SPTA1 Whole Gene Deletion, a Family Study
    Rong He, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
  • Phenotypic Correlates and Prognostic Outcomes of TET2 Mutations in Myelodysplastic Syndrome/Myeloproliferative Neoplasm Overlap Syndromes: A Comprehensive Study of 504...
    Rong He, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
  • Acute Myeloid Leukemia with High Risk Features: Routine Central Nervous System Evaluation May be Beneficial
    Rong He, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • Join now to see all

Lectures

  • Current Status of Clinical Laboratory Testing of Plasma Cell Neoplasms: A Case-Based Approach 
    61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
  • A Phase II of Combination Daunorubicin and Cytarabine (Ara-c) and Nilotinib (TAsigna) (DATA) in Patients Newly Diagnosed with Acute Myeloid Leukemia and KIT Expression... 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018

Hospital Affiliations

Dr. Rong He, Dr. Rong He, MD, Dr. R He